{"name":"Merz Therapeutics GmbH","slug":"merz-therapeutics-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNc0JRaTJmdjNrSnV0eDJjVURZS1dSck5kRlc3cVdxUWJ0Yi10N0hUSVJ0Y2dHUUM0YVJuWWYtYU1tTHFSMklxU0t0VjNxWngxT2FzQm5Ta01VWndha2FGTDE5QUF0X0psWUtnbldadVRTWkN2c3RjX0hZR0FEVk0xaDRIOF83UHlzUUt6emZzWjNjWUZjakYxakhRX2VQSVd3QklIX0Z1QjN1SWo2Q3N3aTZXZlJVQldyRWY5dVZOQm9NZlVzTUF5REkxSFZOdjNOTDYwUWhxWHlVVTdzeUZLbzlsOFVTcGx5?oc=5","date":"2026-04-02","type":"pipeline","source":"European Medical Journal","summary":"Expert Insights on Overcoming Gastrointestinal Challenges While Treating OFF Episodes in Parkinson’s Disease - European Medical Journal","headline":"Expert Insights on Overcoming Gastrointestinal Challenges While Treating OFF Episodes in Parkinson’s Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxQTzVNcDlCcjQ1X2JNUXBTQzNZN19UWTMxQTNjdFpaOHpfUGhEWDJ5MFhXajZQMjZReWF4ZHhxTmFWaUYwMC0zYjFNa0llRi0tdHF3TEFGUUFLaWx3dVk0MzVYTm9Ja1NLVHUxY05Gem1fbktPZTJsTFpscW5BalVua050NG1RUjhmakdPZGdlNlFDdi1VNE5IOVhadV9SQWw2U0lIakNxNXJneUJYY0hydUo0VFJUZnBDWThNVExBb3JkbTBHVmpoMjBZUy1pSkNwMTdQR2xRTTlzM1Nvd0ttNHFSc3N3VWREODE4c1FCWmk5ZGJPdlE?oc=5","date":"2026-01-26","type":"pipeline","source":"BioSpace","summary":"Merz Therapeutics Submits Application to the European Medicines Agency for New Indication of XEOMIN® in Pediatric Spasticity - BioSpace","headline":"Merz Therapeutics Submits Application to the European Medicines Agency for New Indication of XEOMIN® in Pediatric Spasti","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNa09VVmI4RzZUTUtuV0dCNEc2WWxiS2lSbW1oVlFCRk1XVlBOU1pWOFZTN0FYUFJ5dGdwSVlMdFM3WjlWSV9yN2UyNWg2cEtWQXdrdVhOUnBOVGdVZlkwVjRpUTBSa2pLWjlVVXUybmJaam5ib3h6R1hOX0JXV19LOENPalNYSHl6RG5XZ2hNRHY3US1GZVFhWTU1U3N0a21ZZWNnWWU0NHNQQXpORk5WcjJmMXB0aDlBMUctVTFacjRnUzlQQ1JmSU5MSTRFcUZ5Uzl3TFM1bmNSWVR1NFBydnJKcFhTemc5UFBLaQ?oc=5","date":"2025-12-08","type":"trial","source":"Business Wire","summary":"Merz Therapeutics to Present Broad Range of Clinical, Real-World and Mechanistic Data at TOXINS 2026 - Business Wire","headline":"Merz Therapeutics to Present Broad Range of Clinical, Real-World and Mechanistic Data at TOXINS 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPc2xIUUYtSFB0MGhhWUhReFM2T3pBSXQ1cFI1RGFsbV9yOTVNcnZwV3drYmVCUXlsOGxjVHduNHB6dDhYaTNMS0YtazdoaHhXZGp3bkd5b3ZpWmpSMkJOUWNzOWJ4eU1WQXo0MjNZa2FEdTBhQ3R5MmVUbkNSZ3pkZnl6dFNtaTMwdzJ4MnlxUzFuT3J1TDQwLVJudzJqQmNxd2FEeDU4X1ZxVlljNlEtbW5sWER4ZXJwYzIzOQ?oc=5","date":"2025-10-07","type":"pipeline","source":"Business Wire","summary":"Merz Therapeutics Expands Presence with New Affiliate in Poland - Business Wire","headline":"Merz Therapeutics Expands Presence with New Affiliate in Poland","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQWGJoc2ZlVUhnUExnejhfZW1yQ1ZaRXBBakE4Qm43UUNpRFJsQnBtT3VuV1g4UkNsanZXcUwtLWJLMjFFUEttU1NiZGZQNFRZdWZiWmRINHpKbEdBMTdFZGRuVHo0NFMwaTFzZDRaSHV2Tm5reXJfU3FtOFpJRXJIZlFRMkZVQTFPRkRSbV9hZHp3QQ?oc=5","date":"2025-08-25","type":"trial","source":"Yahoo Finance","summary":"Merz Therapeutics Announces First Patients Enrolled in Two Phase III Trials Investigating XEOMIN® (incobotulinumtoxinA) for Migraine Prevention - Yahoo Finance","headline":"Merz Therapeutics Announces First Patients Enrolled in Two Phase III Trials Investigating XEOMIN® (incobotulinumtoxinA) ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQVTdNVVJjdFN4aUNCSW9ZaHVKbDhPNUZ6TzVpMm1VV282RFJwdjZRZlQ2ZHZLVmRhRkhLajktMFowUWJZYmtQS0FOWkZpSnA4R1QxNVFlNXBaVVFueVB1dV80dXhycmFvVWE0Wm90WjEyZG1VamU5WkpCWVlXWFhoWmU1ZHZTUGw4OWc0MGRVMk5veWcwWjVhYWhKMC0xaTJHY1dYd21VV1NKbExS?oc=5","date":"2025-08-11","type":"patent","source":"JUVE Patent","summary":"Carpmaels and A&O Shearman file first SPC suit at UPC for Merz against Viatris - JUVE Patent","headline":"Carpmaels and A&O Shearman file first SPC suit at UPC for Merz against Viatris","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxPcmRlLXJwMDJDYTR5ejhyU053ZHlWRkI5ckMyaFEtWXRMTWROcDJSM29fY0wtMVNRZjZuZFFObGtObE51NHZuUE1KZ2l5Y1lZb2pTdmNaVzl2N3B6cWhYa3BrVjd6dEFITlRweDFCb3NVQzc0c1ZMM3V4WjlHWlpZLVlzNUNZOVRBUWxJbVBhaGhUaC01b2UySW8yLTVjMWZBMkhmSlpNbE5lMnd0ZUw4cEVJZFhoWm4xQnZDcWpQaERvODVOR0JnWjZ4UklpbGxwci1LcmY1THFPUEtLMU5ZZmZsRldkNkJfZVlaRDlsQjNnaU9OaVdsc3Q0cGRiX2NhZEJuWg?oc=5","date":"2024-12-17","type":"regulatory","source":"BioSpace","summary":"Health Canada Approves XEOMIN® (incobotulinumtoxinA) for Treatment of Adults with Post-stroke Lower Limb Spasticity in the Ankle and Foot - BioSpace","headline":"Health Canada Approves XEOMIN® (incobotulinumtoxinA) for Treatment of Adults with Post-stroke Lower Limb Spasticity in t","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQdjdNZmlWb0hfYjhwM2JsZjBlaFRYM3UzdlFqRE5PanlXZ0FvT25OMEtHdnlxN3dBVkUxRy1ScXRlbEsxY3owX3RsT3J6TUxHdENEcEM0ZTluUHlUcjQtd29mdWFwbXVMYTRqOHp5anlvOExXdWlKdVlRcHRuVlo2LU1udlMyUEZ2TWNCTV81NWViTHdyNTdNZHpn?oc=5","date":"2024-11-14","type":"regulatory","source":"Fierce Pharma","summary":"FDA slams Merz over 'misleading' Instagram ad for Botox rival - Fierce Pharma","headline":"FDA slams Merz over 'misleading' Instagram ad for Botox rival","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPT2xkU1ZudUtLSUlGdEZjQUFYZmFnZE9UY3BWVWM2QmxVR0dXUmk0bkwtTGx2eHJQd3VETXVQUkpzaFNfeEFvTERYYmhpZkttaUNLN3RaTUtXMVJzbDJ1YldxV2ZCQ1hTZHBETEV0TGdyNTFiR3JOMEYzQk1xX1R0Znp4R01zY0t6bk1CRU56R1UwNHIwTERKVGZHM1EyTGJnRVJYd0hiMm5PUWtFUWRUNjRiUEJzUTBINTRfT0xjTVhNaVY4ZlNr?oc=5","date":"2024-07-11","type":"deal","source":"Fierce Pharma","summary":"After $185M asset buy, Merz Therapeutics plots US workforce expansion as CEO eyes more deals - Fierce Pharma","headline":"After $185M asset buy, Merz Therapeutics plots US workforce expansion as CEO eyes more deals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPUGtZNldMbVhhT2J1NVdxbXNNTlZuSnpnc2djai1QTERJcWw1RU9BYjJybElQb3ZGU3plcXMweHM5NGJ0MUd0QXI0S213Ync0MUZra3A0WGtwemdpaWNMWG9IdklwMVZNWjJscjV3Uk41XzdKck5VZE9fTUhHTGlVMm5lWlVzUHFmSl9EWU04blo0MHRGTXdfSFR3ckZCLXFsa1E?oc=5","date":"2024-04-02","type":"pipeline","source":"The Business Journals","summary":"Merz offers $185 million for assets of bankrupt biotech - The Business Journals","headline":"Merz offers $185 million for assets of bankrupt biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQWTRZOXRZUWc4aTZyTGhiUXZCZXY0Zkl6SUJnMTlyQmlMbkRoLWNsZDd6aFBOcEZBTHFGaU5DVWlxLU9hQlZoYTUwcnRJVzJkNjVRalJWUUZBRHhTVFV5MVJvNUNBRk5WUmlDRW9pb193SUFyMFhBTmI2UG1CdVd3aGpkcmpxWHE0eVRvbkUyZFhPTzhSWXdRSG5Ha3g2SHNMX0pkMDBzbmx1TWhfdFNwLTBCbVY5ZzJraWhjVmtmbw?oc=5","date":"2023-06-28","type":"pipeline","source":"STT Info","summary":"Merz Therapeutics Expands Business with New Nordics Affiliate - STT Info","headline":"Merz Therapeutics Expands Business with New Nordics Affiliate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQdE53MVRyckVVNF8za1BHeC1ITkpnMHhoTG5OYWRMR1BzaEJtaWUwd1VvbDZNdWxPejgxdklScERzUTF1ZmZ3bUtHV1drOEFQb0xjcmNYZ0RpU1ZYazFESU5RQ3RoamFIdVEzVHNkSkxBTDlLWEtOQ0RVV0k0MUNzQlhyeWlKVTU0Q3ZMYzN5NlZXZHdCVTB3Wm5fLS1yUTg?oc=5","date":"2023-03-01","type":"pipeline","source":"Business Wire","summary":"New CEO for Merz Therapeutics: Stefan König - Business Wire","headline":"New CEO for Merz Therapeutics: Stefan König","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}